| Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy Y Si, Y Xu, JS Guan, K Chen, S Kim, ES Yang, L Zhou, XM Liu Engineering in Life Sciences 21 (1-2), 37-44, 2021 | 31 | 2021 |
| Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers Y Si, Y Zhang, JS Guan, HG Ngo, A Totoro, AP Singh, K Chen, Y Xu, ... Vaccines 9 (8), 882, 2021 | 22 | 2021 |
| Monoclonal antibody-based cancer therapies Y Si, AL Melkonian, KC Curry, Y Xu, M Tidwell, M Liu, AF Zaky, XM Liu Chinese Journal of Chemical Engineering 30, 301-307, 2021 | 20 | 2021 |
| Dual-targeted extracellular vesicles to facilitate combined therapies for neuroendocrine cancer treatment Y Si, JS Guan, Y Xu, K Chen, S Kim, L Zhou, R Jaskula-Sztul, XM Liu Pharmaceutics 12 (11), 1079, 2020 | 20 | 2020 |
| Targeted liposomal chemotherapies to treat triple-negative breast cancer Y Si, Y Zhang, HG Ngo, JS Guan, K Chen, Q Wang, AP Singh, Y Xu, ... Cancers 13 (15), 3749, 2021 | 19 | 2021 |
